Trident Texofab Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

10.07

10.07

10.07

4.00

4.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

0.20

0.20

Reserves & surplus

5.11

2.89

1.91

7.43

6.80

Loan funds

Secured loans

34.65

35.99

29.15

20.37

12.85

Unsecured loans

-

-

-

-

-

Total

49.83

48.95

41.12

31.99

23.84

Uses of funds

Fixed assets

Gross block

28.56

25.43

16.75

14.18

3.27

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

5.23

3.72

2.54

1.70

0.91

Net block

23.33

21.71

14.21

12.48

2.36

Capital work-in-progress

-

3.62

8.89

0.30

6.39

Investments

3.64

2.06

2.48

1.12

1.42

Net current assets

Current assets, loans & advances

50.34

43.60

42.18

41.78

36.88

Less : current liabilities & provisions

27.48

22.04

26.65

23.68

23.20

Total net current assets

22.86

21.55

15.53

18.09

13.68

Miscellaneous expenses not written

-

-

-

-

-

Total

49.83

48.95

41.12

31.99

23.84

Notes:

Book value of unquoted investments

3.64

2.06

2.48

1.12

0.90

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

1.44

1.44

1.44

1.44

0.39

Number of equity sharesoutstanding (Lacs)

100.70

100.70

100.70

39.96

39.96